226 related articles for article (PubMed ID: 24342076)
1. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
[TBL] [Abstract][Full Text] [Related]
4. Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injury.
Cheng Z; DiMichele LA; Hakim ZS; Rojas M; Mack CP; Taylor JM
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):924-33. PubMed ID: 22383703
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.
Xia P; Chen J; Liu Y; Fletcher M; Jensen BC; Cheng Z
J Biol Chem; 2020 Mar; 295(13):4265-4276. PubMed ID: 32075913
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism.
Maruyama S; Shibata R; Ohashi K; Ohashi T; Daida H; Walsh K; Murohara T; Ouchi N
J Biol Chem; 2011 Sep; 286(37):32790-800. PubMed ID: 21784858
[TBL] [Abstract][Full Text] [Related]
8. FAK regulates cardiomyocyte survival following ischemia/reperfusion.
Hakim ZS; DiMichele LA; Rojas M; Meredith D; Mack CP; Taylor JM
J Mol Cell Cardiol; 2009 Feb; 46(2):241-8. PubMed ID: 19028502
[TBL] [Abstract][Full Text] [Related]
9. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
10. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
Jing X; Yang J; Jiang L; Chen J; Wang H
Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
[TBL] [Abstract][Full Text] [Related]
13. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
14. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
[TBL] [Abstract][Full Text] [Related]
15. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
16. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
Lv X; Yu X; Wang Y; Wang F; Li H; Wang Y; Lu D; Qi R; Wang H
PLoS One; 2012; 7(10):e47351. PubMed ID: 23077597
[TBL] [Abstract][Full Text] [Related]
18. Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation.
Wen SY; Tsai CY; Pai PY; Chen YW; Yang YC; Aneja R; Huang CY; Kuo WW
Environ Toxicol; 2018 Jan; 33(1):93-103. PubMed ID: 29087013
[TBL] [Abstract][Full Text] [Related]
19. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
20. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.
Venkatakrishnan CD; Dunsmore K; Wong H; Roy S; Sen CK; Wani A; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1736-44. PubMed ID: 18263706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]